e-learning
resources
Vienna 2012
Monday, 03.09.2012
Management of severe respiratory infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Inhaled colistin in elderly patients with bronchiectasis and chronic bronchial infection with pseudomonas
E. Tabernero, R. Alkiza, P. Gil, J. Garros, D. Cantero, J.L. Artola, L. Ramos (Bilbao, Galdakao, Spain)
Source:
Annual Congress 2012 - Management of severe respiratory infections
Session:
Management of severe respiratory infections
Session type:
Thematic Poster Session
Number:
2464
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Tabernero, R. Alkiza, P. Gil, J. Garros, D. Cantero, J.L. Artola, L. Ramos (Bilbao, Galdakao, Spain). Inhaled colistin in elderly patients with bronchiectasis and chronic bronchial infection with pseudomonas. Eur Respir J 2012; 40: Suppl. 56, 2464
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials
A 62-year-old man with scanty mucoid sputum
Related content which might interest you:
Effectiveness of inhaled colistin by iNeb® device in non-CF bronchiectasis and chronic pseudomonas infection
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation
Year: 2015
Inhaled antibiotics in chronic airway infections
Source: Eur Respir Monogr 2017; 75: 57-79
Year: 2017
Inhaled colistin in patients with non - cystic fibrosis bronchiectasis and chronic pseudomonas aeruginosa bronquial infection
Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Year: 2016
The clinical impact of nebulised antibiotics in adults with bronchiectasis and chronic pseudomonas aeruginosa
Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis
Year: 2020
Efficacy of moxifloxacin in the treatment of bronchial colonisation in COPD
Source: Eur Respir J 2009; 34: 1066-1071
Year: 2009
Impact of inhaled corticosteroid use on outcome in COPD patients admitted with pneumonia
Source: Eur Respir J 2011; 37: 36-41
Year: 2011
Nebulized antibiotics in patients with non-cystic fibrosis bronchiectasis ans chronic pseudomonas aeruginosa infection
Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis
Year: 2011
The low dose macrolides for prevention of exacerbations in non-CF bronchiectasis
Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care
Year: 2015
Azithromycin in chronic respiratory infections with
pseudomonas aeruginosa
in patients without cystic fibrosis
Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host
Year: 2008
Tolerance test for inhaled antibiotics in patients with chronic bronchial infection
Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease
Year: 2018
Penetration of moxifloxacin in bronchial secretions in hospitalized patients with acute exacerbation of COPD
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013
Inhaled corticosteroid use is associated with lower mortality for subjects with COPD and hospitalised with pneumonia
Source: Eur Respir J 2010; 36: 751-757
Year: 2010
Inhaled corticosteroids and pneumonia mortality in COPD patients
Source: Eur Respir J, 54 (3) 1901035; 10.1183/13993003.01035-2019
Year: 2019
Inhaled corticosteroids and pneumonia mortality in COPD patients
Source: Eur Respir J, 54 (3) 1901276; 10.1183/13993003.01276-2019
Year: 2019
Exacerbations and inhaled corticosteroids in bronchiectasis patients
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019
Role of inhaled corticosteroids on recurrent bronchial infection by potentially pathogenic bacteria in patients with COPD
Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils
Year: 2020
Non-CF bronchiectasis: nebulised colistimethate sodium improves symptoms and bacterial load in sputum of patients with pseudomonas aeruginosa
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008
Inhaled colistin following lung transplantation in colonised cystic fibrosis patients
Source: Eur Respir J 2013; 42: 542-544
Year: 2013
Patients with no cystic fibrosis bronchiectasis colonized by
pseudomonas aeruginosa
: Role of inhaled colistin
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014
Inhaled antibiotics in non-cystic fibrosis bronchiectasis: better than oral antibiotics?
Source: International Congress 2016 – PG13 Inhaled antibiotics in respiratory infections
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept